Analisis Bibliometrik tentang Distribusi Vaksin Covid-19 Tahun 2020-2021

Desi Kusumawati; Dyah Aryani Perwitasari; Woro Woro Supadmi Supadmi

doi:10.22146/farmaseutik.v20i4.100082

Analisis Bibliometrik tentang Distribusi Vaksin Covid-19 Tahun 2020-2021

https://doi.org/10.22146/farmaseutik.v20i4.100082

Desi Kusumawati^(1*), Dyah Aryani Perwitasari⁽²⁾, Woro Woro Supadmi Supadmi⁽³⁾

(1) Program Studi S3 Farmasi, Fakultas Farmasi Universitas Ahmad Dahlan Yogyakarta
(2) Program Studi S3 Farmasi, Fakultas Farmasi Universitas Ahmad Dahlan Yogyakarta
(3) Program Studi S1 Farmasi, Fakultas Ilmu Kesehatan dan Sains Universitas PGRI Madiun
(*) Corresponding Author

Abstract

Covid-19 is an infectious disease that has caused the highest mortality since 2019. This study aims to determine the map of research developments related to ‘Covid-19 Vaccines’. This article review was conducted by searching for publications through the Pubmed database in October-November 2021 with the keyword ‘Vaccines/supply and distribution’. The publication map in this study researchers used bibliometric analysis of the Biblioshiny web interface application for the article search period during 1 January 2020 - 30 November 2021 in Pubmed found around 6528 articles. The article that ranked first out of 1406 articles was The New Englands Journal Of Medicine with 214 articles (15.22%), Vaccine with 208 articles (14.79%), and Nature with 189 articles (13.44%). The most authors out of 444 authors were Baden LR with 63 articles (14.19%), Rubin Ej with 57 articles (12.84%) and Morrisey S with 56 articles (12.61%). Institutions or institutions dominated by European-American origin ranked first University Of Oxford with 1229 articles (29.57%), followed by Harvard Medical School with 484 articles (11.65%), followed by the National Institute Of Allergy And Infectious Diseases with 376 articles (9.05%). The most keywords in Pubmed searches in the period during the study were related to Covid-19 Vaccine/supply & distribution in a table showing keywords with the word Human had a frequency of use of 6432 times (98.52%) then keywords with the word sars-cov-2 had been used 3275 times (50.2%) then the 3rd highest was keywords with the word covid-19 vaccines had been used 3268 times (50.1%) of the total number of articles available. Author productivity is mostly dominated by European countries, namely Argentina and Afghanistan.

Keywords

vaksin covid; supply; distribution; bibliometrix

References

Adejumo, O. A., & Adejumo, O. A. (2021). Recalling the universal health coverage vision and equity in the covid-19 vaccine distribution plan. Pan African Medical Journal, 39. https://doi.org/10.11604/pamj.2021.39.197.29041

Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., McGettigan, J., Khetan, S., Segall, N., Solis, J., Brosz, A., Fierro, C., Schwartz, H., Neuzil, K., Corey, L., … Zaks, T. (2021). Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine, 384(5), 403–416. https://doi.org/10.1056/nejmoa2035389

Belter, C. W. (2015). Bibliometric indicators: Opportunities and limits. Journal of the Medical Library Association, 103(4), 219–221. https://doi.org/10.3163/1536-5050.103.4.014

Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di, J. D., Cao, B., Lin, K., Mansur, R. B., Ho, R. C., & Rosenblat, J. D. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID- 19 resource centre is hosted on Elsevier Connect, the company’s public news and information. January.

Chen, Y., & Li, L. (2020). SARS-CoV-2: virus dynamics and host response. The Lancet Infectious Diseases, 20(5), 515–516. https://doi.org/10.1016/S1473-3099(20)30235-8

Chishinga, N., Smith, S., Gandhi, N. R., Onwubiko, U. N., Telford, C., Prieto, J., Chamberlain, A. T., Khan, S., Williams, S., Khan, F., & Sarita Shah, N. (2022). Characteristics and Risk Factors for Mortality by Coronavirus Disease 2019 Pandemic Waves in Fulton County, Georgia: A Cohort Study March 2020–February 2021. Open Forum Infectious Diseases, 9(4), ofac101. https://doi.org/10.1093/ofid/ofac101

Du, Y., Chen, L., & Shi, Y. (2022). Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta- Analysis. Frontiers in Public Health, 10 (April). https://doi.org/10.3389/fpubh.2022.829176

Forni, G., Mantovani, A., Forni, G., Mantovani, A., Moretta, L., Rappuoli, R., Rezza, G., Bagnasco, A., Barsacchi, G., Bussolati, G., Cacciari, M., Cappuccinelli, P., Cheli, E., Guarini, R., Bacci, M. L., Mancini, M., Marcuzzo, C., Morrone, M. C., Parisi, G., … Vineis, P. (2021). COVID-19 vaccines: where we stand and challenges ahead. Cell Death and Differentiation, 28(2), 626–639. https://doi.org/10.1038/s41418-020-00720-9

Gathiram, P., Moodley, J., & Khaliq, O. P. (2021). Covid-19 pandemic: Perspectives on management. Journal of Reproductive Immunology, 146(February), 103344. https://doi.org/10.1016/j.jri.2021.103344

Harris, M., Hart, J., Bhattacharya, O., & Russell, F. M. (2019). Risk factors for SARS-CoV- infection during the early stages of the COVID- pandemic: a systematic literature review. 2(1).

Liu, Y., Finch, B. K., Brenneke, S. G., Thomas, K., & Le, P. D. (2020). Perceived discrimination and mental distress amid the COVID-19 pandemic: evidence from the understanding America study. American Journal of Preventive Medicine, 59(4), 481–492. Luiza, A., Martimbianco, C., Pacheco, R. L., Bagattini, Â. M., & Riera, R. (2021). Frequency, signs and symptoms, and criteria adopted for long 19: A systematic review. May, 1–16. https://doi.org/10.1111/ijcp.14357

Mohamed, K., Rodríguez-Román, E., Rahmani, F., Zhang, H., Ivanovska, M., Makka, S. A., Joya, M., Makuku, R., Islam, M. S., Radwan, N., Rahmah, L., Goda, R., Abarikwu, S. O., Shaw, M., Zoghi, S., Irtsyan, S., Ling, I., Cseprekal, O., Faten, A. B., … Rezaei, N. (2020). Borderless collaboration is needed for COVID-19 - A disease that knows no borders. Infection Control and Hospital Epidemiology, 41(10), 1245–1246. https://doi.org/10.1017/ice.2020.162

Ophinni, Y., Hasibuan, A. S., Widhani, A., Maria, S., Koesnoe, S., Yunihastuti, E., Karjadi, T. H., Rengganis, I., & Djauzi, S. (2020). COVID-19 Vaccines: Current Status and Implication for Use in Indonesia. Acta Medica Indonesiana, 52(4), 388–412.

Perdhana, F. F. (2021). Pemetaan Penelitian Bioteknologi terkait Vaksin Covid-19 dan Kontribusi Indonesia: Analisis Bibliometrik selama Pandemi Covid-19 Tahun 2020. Gunung Djati Conference Series, 6, 128–140.

Phannajit, J., Takkavatakarn, K., Katavetin, P., Asawavichienjinda, T., Tungsanga, K., Praditpornsilpa, K., Eiam-Ong, S., & Susantitaphong, P. (2021). Factors Associated with the Incidence and Mortality of Coronavirus Disease 2019 (COVID-19) after 126- million Cases: A Meta-analysis. Journal of Epidemiology and Global Health, 11(3), 289–295. https://doi.org/10.2991/jegh.k.210527.001

Pieri, M., Nicolai, E., Ciotti, M., Nuccetelli, M., Sarubbi, S., Pelagalli, M., & Bernardini, S. (2022). Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution. International Immunopharmacology, 102(November 2021), 108406. https://doi.org/10.1016/j.intimp.2021.108406

Ramanathan, K., Antognini, D., Combes, A., Paden, M., Zakhary, B., Ogino, M., Maclaren, G., & Brodie, D. (2020). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- research that is available on the COVID-19 resource centre - including this for unrestricted research re-use a. January, 19–21.

Skafle, I., Nordahl-hansen, A., Quintana, D. S., & Wynn, R. (2022). Misinformation About COVID-19 Vaccines on Social Media: Rapid Review Corresponding Author: 24, 1–20. https://doi.org/10.2196/37367

Tatar, M., Faraji, M. R., Montazeri Shoorekchali, J., Pagán, J. A., & Wilson, F. A. (2021). The role of good governance in the race for global vaccination during the COVID-19 pandemic. Scientific Reports, 11(1), 1–7. https://doi.org/10.1038/s41598-021-01831-0

Velikova, T., & Georgiev, T. (2021). SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatology International, 41(3), 509–518. https://doi.org/10.1007/s00296-021-04792-9

WHO. (2020). Coronavirus Disease 2019 Situation Report 1 - 21 January 2020. Geneva: World Health Organization, January, 1–5.

Young, J., Thone, M. N., & Jik, Y. (2020). Since January 2020 Elsevier has created a COVID- 19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect, the company’s public news and information. Advanced Drug Delivery Reviews j, January, 25.

Zeng, B., Gao, L., Zhou, Q., Yu, K., & Sun, F. (2022). Effectiveness of COVID - 19 vaccines against SARS - CoV - 2 variants of concern: a systematic review and meta - analysis. BMC Medicine, 1–15. https://doi.org/10.1186/s12916-022-02397-y

DOI: https://doi.org/10.22146/farmaseutik.v20i4.100082